SCHEDULE: Lincoln Alternative Strategies Reports 0% Stake in Celularity

Lincoln Alternative Strategies LLC has filed an amended Schedule 13G, indicating it no longer holds a beneficial ownership stake in Celularity Inc.

Summary

• Lincoln Alternative Strategies LLC filed an Amendment No. 1 to Schedule 13G regarding Celularity Inc.'s Class A Common Stock.
• The filing reports that Lincoln Alternative Strategies LLC beneficially owns 0 shares of Celularity Inc.
• This represents 0% of the Class A Common Stock of Celularity Inc.
• The CUSIP number for the securities is 151190204.
• The reporting person, Lincoln Alternative Strategies LLC, is organized in Delaware and has its principal business office at 404 Washington Ave., Suite 650, Miami Beach, FL 33139.

Sentiment

Score: 5

Explanation: StockSavvy.ai views this as neutral, as it is a standard regulatory filing indicating a change in beneficial ownership to zero, with no direct impact on Celularity's operations or financial health.

Management Comments

• Stephen Temes, Managing Member of Lincoln Alternative Strategies LLC, certified that the information set forth in the statement is true, complete, and correct to the best of his knowledge and belief.

Industry Context

StockSavvy.ai notes this is a routine regulatory disclosure of a change in beneficial ownership, common for institutional investors adjusting their portfolios. Such filings provide transparency into significant ownership stakes but do not typically reflect operational or strategic changes within the issuer company.

Stakeholder Impact

• Shareholders: Minimal direct impact, as the filing simply reports a change in an institutional investor's stake to zero, which is not indicative of the company's performance or future prospects.

Key Dates

Keywords

Celularity Inc., Lincoln Alternative Strategies LLC, Schedule 13G, Beneficial Ownership, Class A Common Stock, SEC Filing